Halozyme Therapeutics Inc (HALO)

[rod5247]

As of Q3, 2015 call, over 100 enrolled. EOY 2015, 120 enrolled. Mid Feb 2016, 133 enrolled and enrollment closed.

The original number for stage II was 100 and was completed as projected but Halo decided to increase that number by 33%.

Phase III protocol was approved based on stage I data and the impression I got at the time was Phase II really doesn't matter but of course we will be interested in the data. Something changed in their opinion between 1st half and 2nd half 2015 about the importance of potential stage II data.

Over 100 patients 13+ months, 120 patients 11+ months, 133 patients 9.5+ months since enrolled. 2:1 ratio 88-89 PAG arm, 44-45 AG arm.